Publicacións en colaboración con investigadores/as de University of Pennsylvania (7)

2024

  1. Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4

    Journal of Cardiac Failure

2023

  1. 2022 Year in Review: Countdown of the Best Manuscripts in 2022

    JACC: Case Reports

  2. Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 81, Núm. 1, pp. 34-45

2020

  1. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet, Vol. 396, Núm. 10253, pp. 759-769

2018

  1. Hemodynamic patterns identified by impedance cardiography predict mortality in the general population: The PREVENCION study

    Journal of the American Heart Association, Vol. 7, Núm. 18

2012

  1. Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency

    American Journal of Transplantation, Vol. 12, Núm. 9, pp. 2487-2497

2010

  1. The international society of heart and lung transplantation guidelines for the care of heart transplant recipients

    Journal of Heart and Lung Transplantation